Updated April 2023.
The editorial team of Diabetes Spectrum welcomes inquiries and submissions from potential authors within the diabetes health care community. We are especially interested in article ideas related to new technologies, protocol development, psychosocial issues, pharmacological therapy, diabetes complications, and exercise in diabetes management. Although some of our articles are invited, unsolicited original submissions are reviewed by the editorial team and considered for publication if they contain information that would be helpful to the journal's readership. All articles should be developed and written with the multidisciplinary diabetes care team in mind as the main audience.
How can I submit an article to the journal?
Manuscripts may be submitted via http://mc.manuscriptcentral.com/diabetes-spectrum. Before submitting an article, please review the various types of articles listed below and click on the appropriate link for further instructions related to the specific type of article you wish to submit. All authors should complete, sign, and return the manuscript submission form before or soon after submitting their article.
ARTICLE TYPES
From Research to Practice articles
Each From Research to Practice section includes a preface, written by the guest editor (GE), and a selection of invited articles presenting different aspects of the topic. Research sections may include a variety of articles of differing lengths, including overview articles offering a general discussion of the main aspects of the topic, case studies and discussions, pro/con articles presenting differing views from diabetes health professionals, summaries of and commentaries on relevant related research articles, and other types of articles. Click here for detailed instructions for writing research section articles.
Feature articles
Feature articles include both invited and unsolicited original manuscripts. Original articles report on quantitative or qualitative research relevant to diabetes care, as well as conceptual materials distilling the literature. Conceptual work should offer new insight, applying topics to clinical practice. Invited feature articles may also report on events, institutions, achievements, and issues in diabetes education and health care. Lengths vary. Click here for detailed instructions for writing feature articles.
If you have questions about whether your article is appropriate for publication in Diabetes Spectrum, please contact Editor-in-Chief Curtis Triplitt at curtis.triplitt@uhs-sa.com.
Departments
Departments encompass the following types of articles, which may be either invited or unsolicited:
Guest editorials, offering brief opinion-based essays or personal insights in diabetes care and education. Word limit: 800-1600 words.
Care Innovations, focusing on innovations in care models, care tools, and practice models. Word limit: 1600-2400 words.
Nutrition FYI, focusing on current topics related to medical nutrition therapy for diabetes. Word limit: 1600-2400 words.
Lifestyle and Behavior, focusing on current topics related to behavioral science, lifestyle interventions, and counseling. Word limit: 1600-2400 words.
Pharmacy and Therapeutics, focusing on current topics related to pharmacy and therapeutics, including updates on medications, treatment algorithms, and innovative pharmacist practice models. Word limit: 1600-2400 words.
Click here for detailed instructions for writing department articles.
If you have questions about whether your article is appropriate for publication in Diabetes Spectrum, please contact Editor-in-Chief Curtis Triplitt at curtis.triplitt@uhs-sa.com.
EDITORIAL OFFICE CONTACT INFORMATION
ADA Editorial Office
9702 East Washington Street
Suite 400, #356
Indianapolis, IN 46229
Phone: (317) 354-1508, ext. 1782
Fax: (317) 547-4656
E-mail: EditorialOffice@diabetes.org
EDITORIAL POLICIES
ADA's Publications Policy Committee follows the recommendations of the International Committee of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), and the Committee on Publication Ethics (COPE) for guidance on policies and procedures related to publication ethics. The policies for Diabetes Spectrum have been adopted from those three advisory bodies and, where necessary, modified and tailored to meet the specific content, audiences, and aims of Diabetes Spectrum. Comprehensive information related to the editorial and ethical policies of Diabetes Spectrum can be found in Publication Policies and Procedures for ADA Journals. The Association's Publications Policy Committee or Subcommittee on Ethical Scientific Publications will consider on a case-by-case basis policies that are not addressed in the policies document, which contains information related to the following topics:
- Study Design
- Originality and Prior Publication
- Authorship and Contributions
- Acknowledgments
- Conflict of Interest
- Clinical Trials, Systematic Reviews, and Meta-Analyses
- Plagiarism
- Digital Image Manipulation
- Responses to Possible Scientific Misconduct
- Peer Review
- Editorial Decisions
- Prepublication of Accepted Articles
- Reuse, Post-Prints, and Public Access
- Errata
- Media Embargos
- Advertising
- Supplements
Post-Prints and Public Access
Authors are permitted to submit the final, accepted version of their manuscript to their funding body or institution for inclusion in their funding body or institution's database, archive, or repository, or to post the final, accepted version on their personal website. These manuscripts may be made freely accessible to the public upon acceptance if certain conditions are observed. For details, please refer to the section on Copyright, Reuse, and Public Access in Publication Policies and Procedures for ADA Journals.
As a courtesy to authors, the final print versions of articles will be deposited in PubMed Central (PMC). In compliance with National Institutes of Health policy, these articles will appear on PMC 12 months after print publication in Diabetes Spectrum and will be indexed on PubMed/Medline.
All articles are freely accessible on Diabetes Spectrum online (diabetesjournals.org/spectrum) 12 months after the print publication date.
Supplemental Material
Nonessential tables, figures, and/or videos may accompany articles as online-only supplemental material files, but authors are asked to include a comment to the editor at the time of manuscript submission that explains the rationale and justification for submitting and possibly posting the supplemental information.
All online-only supplemental material files should be uploaded during the submission process. The file must be clearly labeled as "Online-Only Supplemental Material." In addition, supplemental material online-only files must be referenced in the main text of the manuscript at least once (e.g., Supplemental Table S1).
All online-only supplemental material files are subject to peer review but will not be composed, copyedited, or proofread by production staff. As such, authors are encouraged to review supplemental material files carefully before submission.
Supplemental material containing very large datasets should be cited in the text with a URL to the material hosted on an author-affiliated website or data repository or may appear with a note that the data is available upon request to the author.
ADA partners with Figshare to publish supplemental material online. All supplemental material files accepted for publication with the manuscript will be uploaded to Figshare by ADA production staff and linked to the article on Diabetes Spectrum. View and search all supplemental materials for Diabetes Spectrum on Figshare at diabetesjournals.figshare.com/Spectrum.
